|
|
|
||
Top Stories 31ST
ANNUAL CONVENTION! Legislation Journal
of the American Naturopathic Facts |
ANMA ONLINE REFERENCES Vol. 10 No. 2
Combination of Chinese Herbs Acts as an Aromatase Inhibitor For Estrogen-Related Conditions
By: Tsu-Tsair Chi, NMD, PhD REFERENCES (1) Sassano
H & Harad N. 1998 Intratumoral aromatase in human breast,
endometrial, and ovarian malignancies. Endocrine Review. 19:593-607. (2)
US National Library of Medicine, “Estrogen” <nlm.nih.gov/medlineplus/druginfo/
medmaster/a682922.html> 2006 Mar 21. (3)
Saha, Suparna. “Estrogen Receptor Structure-Function Overview”
Carnegie-Mellon University. Department of Biological Sciences. (4)
Clark, RA, S Snedeker, C Devine. “Estrogen and Breast Cancer Risk:
What is the Relationship?” Program on Breast Cancer and Environmental
Risk Factors. Cornell University. Fact Sheet #9, March 1998.) (5)
Suzuki T, et al. Sex steroid-producing enzymes in human breast cancer.
Endocrine-Related Cancer. 2005; 12:701-20. (6)
Ellem SJ, et al. Local aromatase expression in human prostate is altered
in malignancy. Journal of Clinical Endocrinology & Metabolism. 2004;
89(5): 2434-2441. (7)
Sakkoula E, Pipili-Synetos E, Maragoudakis ME. Involvement of nitric
oxide in the inhibition of angiogenesis by interleukin-2. Br J Pharmacol.
1997; 122(5):793-5. (8)
Wikipedia <http://en.wikipedia.org/wiki/Interferon> 2006 Mar 22. (9)
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N,
Williamson B. An endotoxin-induced serum factor that causes necrosis of
tumors. Proc Natl Acad Sci U S
A 1975;72:3666-70. (10)
Helm, CW. Ovarian Cysts. eMedicine. Sep 16 2005. <http://www.emedicine.com/med/topic1699.htm>
2006 Mar 22. (11)
Thomason, Philip, MD. Leiomyoma,
Uterus (Fibroid). eMedicine.com. 2005 Sep 9. < http://www.emedicine.com/radio/topic777.htm>
2006 Mar 22. (12)
Chi TT. “Benefits of a special sea cucumber extract in anti-angiogenic
therapy and RTK inhibition for cancer.” ANMA Monitor. July 2005; 9(2). (13)
Thurlimann B et al, for the Breast International Group (BIG) 1-98
Collaborative Group. A comparison of Letrozole and Tamoxifen in
postmenopausal women with early breast cancer. New England Journal of
Medicine. 2005; 353: 2747-57. (14)
Nakamura J, Imai E, Yoshihama M, Sasano H, Kubota T. “Histoculture
drug response assay, a possible examination system for predicting the
antitumor effect of aromatase inhibitors in patients with breast cancer.”
Anticancer Research. 1998; 18(1A):125-128. (15)
Ingle JN, Goss PE, et al. Analysis of duration of letrozole extended
adjuvant therapy as measured by hazard ratios of disease recurrence over
time for patients on NCIC CTG MA.17. San Antonio Breast Cancer
Symposium. 9 Dec 2005. (16)
Cohen PG. “The hypogonadal-obesity cycle: role of aromatase in
modulating the testosterone-estradiol shunt--a major factor in the
genesis of morbid obesity.” Medical Hypotheses. 1999; 52(1): 49-51. (17)
Akingbemi, B. “Estrogen regulation of testicular function.” Reproductive
Biology & Endocrinology. 2005; 3:51. (18)
Leffers H, Naesby M, Vendelbo B, Skakkebaek NE, Jorgensen M.
“Oestrogenic potencies of Zeranol, oestradiol, diethylstilboestrol,
Bisphenol-A and genistein: implications for exposure assessment of
potential endocrine disrupters.” Human Reproduction. 2001; 16:1037-1045.
|
||
